Tango Therapeutics (TNGX)
(Real Time Quote from BATS)
$7.56 USD
+0.25 (3.42%)
Updated May 14, 2024 10:32 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For TNGX
-
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Misses Revenue Estimates
-
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
-
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates
-
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Misses Revenue Estimates
-
Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates
-
Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release